ScholarIQanswers from OpenAlex

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

PaperCitations, authors & open-access status

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer have?

ScholarIQcitation count

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer has 176 citations in the OpenAlex counts ScholarIQ stores.

When was Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer published?

ScholarIQyear

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer has 2004 year in the ScholarIQ index.

What is the open-access status of Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer?

ScholarIQoa status

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer has closed oa status in the ScholarIQ index.

What is the DOI of Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer?

ScholarIQdoi

The DOI for Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer is on the source record.

What is the PMID of Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer?

ScholarIQpmid

The PMID for Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer is on the source record.

What is the OpenAlex record for Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer?

ScholarIQopenalex

The OpenAlex for Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial